Sign in
4

Changes in Ownership

Passage BIO, Inc. Filed Acc 0001209191-23-043725

Options or other derivatives

  • SVP, Interim CFO acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Borthwick Kathleen SVP, Interim CFO 2023-07-28 Grant or award · Employee Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X05/doc4.xml…